Naora K, Katagiri Y, Ichikawa N, Hayashibara M, Iwamoto K
Department of Pharmacy, Shimane Medical University Hospital, Izumo, Japan.
J Pharm Pharmacol. 1990 Oct;42(10):704-7. doi: 10.1111/j.2042-7158.1990.tb06563.x.
The change in plasma concentration-time profile, serum protein binding and renal and biliary clearances of ciprofloxacin caused by coadministration of fenbufen has been studied in rats administered an intravenous dose of ciprofloxacin (5 mg kg-1) alone or with fenbufen (10 mg kg-1). Coadministered fenbufen significantly prolonged the plasma elimination half-life of ciprofloxacin from 40.5 to 57.6 min and tended to reduce the total body clearance of this quinolone by about 20%. The extent of ciprofloxacin binding to rat serum protein was not affected by fenbufen, nor did it affect the biliary clearance of the quinolone. However, fenbufen tended to reduce renal clearance and significantly decreased the cumulative renal excretion of the quinolone during at least the first 3 h after drug administration. These results suggest a possible reduction of ciprofloxacin clearance owing to inhibition of renal excretion by fenbufen.
在单独静脉注射环丙沙星(5mg/kg)或与芬布芬(10mg/kg)同时静脉注射的大鼠中,研究了芬布芬的共同给药对环丙沙星血浆浓度-时间曲线、血清蛋白结合率以及肾清除率和胆汁清除率的影响。共同给药的芬布芬显著延长了环丙沙星的血浆消除半衰期,从40.5分钟延长至57.6分钟,并倾向于使这种喹诺酮类药物的总体清除率降低约20%。环丙沙星与大鼠血清蛋白的结合程度不受芬布芬影响,芬布芬也不影响喹诺酮类药物的胆汁清除率。然而,芬布芬倾向于降低肾清除率,并在给药后的至少前3小时内显著减少了喹诺酮类药物的累积肾排泄量。这些结果表明,芬布芬可能通过抑制肾排泄而降低环丙沙星的清除率。